MUC16 and neoplasm: Based on TNM stage, tumor size classification and differentiation, ROC curve analyses indicated that CA125 was a more sensitive serological tumor indicator of clinical outcomes than AFP, CEA, or CA19-9 (all P < .05, Fig. 1A–C).